Global growth worries weighed on the markets after the OECD cut its growth target for the year, citing political uncertainty and trade tensions. The FDA approved a controversial new drug Tuesday that will be used to treat depression. The nasal spray Spravato, manufactured by Johnson & Johnson, is made with a chemical almost identical to ketamine, a popular party drug. Plus, Alex Ring and Maxime Chanot from the NYCFC join Cheddar to discuss their upcoming season in the MLS and the growth of soccer here in the United States.